About

Roshan Kumar is the Head of Research at HiFiBiO Therapeutics. He is a scientist with over 15 years of experience in the study of complex biological systems. Roshan leads US External Innovation activities to identify high impact partnerships and collaborations for the company’s internal pipeline and DIS® platform.

Roshan’s previous research was focused on the study of transcriptional regulatory networks in mammalian systems, and on understanding how cellular heterogeneity influences fate decisions in individual pluripotent stem cells.

Roshan received a B.S. from the California Institute of Technology and Ph.D. in Biochemistry from the Scripps Research Institute. His postdoctoral studies were performed at the Whitehead Institute for Biological Research at MIT and the Wyss Institute for Biologically Inspired Engineering at Harvard Medical School.